{"id":12132,"date":"2025-03-13T21:02:36","date_gmt":"2025-03-13T20:02:36","guid":{"rendered":"https:\/\/valintermed.com\/?p=12132"},"modified":"2025-03-13T21:02:36","modified_gmt":"2025-03-13T20:02:36","slug":"myshechno-invazivnyy-rak-mochevogo-puzyrya","status":"publish","type":"post","link":"https:\/\/valintermed.com\/en\/medlibrary\/myshechno-invasive-cancer-of-the-urinary-bladder\/","title":{"rendered":"Muscle invasive bladder cancer"},"content":{"rendered":"
<\/div>\n

Muscle-invasive bladder cancer (MIBC) is one of the most aggressive forms of bladder surface cancer, characterized by tumor invasion into the underlying muscle of the organ. This type of cancer is usually classified by stages, where the tumor invades the muscle layer, which significantly worsens the prognosis and requires a more intensive treatment approach. From the time of diagnosis of MIBC, the involvement of adjacent tissues and the presence of metastases to lymph nodes and other organs often become a subject of discussion during the development of an effective treatment strategy. Muscle-invasive bladder cancer is associated with multiple factors, including smoking, chemical exposure and chemotherapeutic agents. To date, despite ongoing efforts to understand the mechanisms of the disease, the survival rate of patients with MIBC remains quite low, which emphasizes the importance of early diagnosis and individualized treatment.<\/p>\n

\n
\n

Content<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n